Products

Smartlinks

Ludicrously fast link building

smartlinks.ai Marketing / Backlinks & Launch Directories

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Shyamal Parikh
@shyamal890· 814 followers
Launched
3y ago
2023-01-24 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending
Events3 changes

Marketing moves

Launches, search & content, referrals, promotions
X accounts@shyamal890@smarttask_io@smarttask_io

  • New product launchLaunch

    Jan 24, 2023 · 3y agoWebsite

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search33%
  • Referrals10%
  • Social6%
  • Other12%

Countries

  • India53%
  • United States47%

Search

Domain authority —Domain registered 2023-01-24

KeywordMonthly volume
smart link3,270
smart links1,900
smartlinks1,070
guest posting services520
abc link exchange440

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-08-08

Key pages

Weekly snapshots
Home
www.smartlinks.ai/ Snapshot 2026-11-04

Changes

  1. Nov 1 · 14d ago

    Removed technology: HubSpotFeatures

    HubSpot→—

  2. Nov 1 · 14d ago

    Removed technology: HubSpot AnalyticsFeatures

    HubSpot Analytics→—

  3. Nov 1 · 14d ago

    Removed technology: core-jsFeatures

    core-js→—

Questions & evidence

How much website traffic does Smartlinks get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Smartlinks and what platforms does it support?
Smartlinks is catalogued under Backlinks & Launch Directories: Ludicrously fast link building. Supported platforms: API.

Related products in this category

Marketing / Backlinks & Launch Directories

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.